AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 116 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,951,000 | +49.9% | 105,053 | +102.0% | 0.03% | +36.8% |
| Q2 2019 | $1,969,000 | -26.5% | 52,000 | -24.3% | 0.02% | -32.1% |
| Q1 2019 | $2,679,000 | +207.6% | 68,658 | +68.0% | 0.03% | +180.0% |
| Q4 2018 | $871,000 | -28.5% | 40,862 | +32.8% | 0.01% | -33.3% |
| Q3 2018 | $1,219,000 | +76.2% | 30,779 | +70.0% | 0.02% | +66.7% |
| Q2 2018 | $692,000 | +54.5% | 18,100 | +21.5% | 0.01% | +28.6% |
| Q1 2018 | $448,000 | +54.0% | 14,900 | +60.2% | 0.01% | +40.0% |
| Q4 2017 | $291,000 | – | 9,302 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |